Incorporated in Ontario, Canada.
Developing FDA pharma-grade, patented & formulated treatments for the international market. 3 Orphan Drugs, 1 lifesaving.
Exclusive JV and licensing agreements with Israel’s National Research Lab at ARO Volcani headed by Professor Hinanit Koltai in Collaboration with Rabin Medical Center, Department of Dermatology, headed by Professor Emilia Hodak.
Leishmaniasis treatments LeshmanX® being developed by fully-owned Israeli subsidiary: Naturacare Therapeutics